Biotech Values

[jbog]

Biowatch,

When I read your snippet from the other day I didn't understand their point.

The good news: they found that the risk of cardiovascular disease in patients who consistently took GLP-1s over three years fell by 18 percent, backing up a wealth of research demonstrating its health benefits beyond simply losing weight.

And now for the bad: quitting GLP-s for as short a period as six months, the study found, spiked their risk of a major cardiovascular event by as much as 8 percent. And those who stopped taking them for one or two years saw their risk shoot up by 22 percent, wiping out the protection the drug offered.

Did anyone ever think if you took a glp-1 drug the benefit would be forever?

Patients improve 18% and then reverse (from the 82% level) 22% puts you back at 100